Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE ...
Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...
Angiotensin-converting–enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...
The European Medicines Agency (EMA) has issued a statement reiterating that people should continue to take certain blood pressure medicines during the COVID-19 pandemic. Recent observational studies, ...
Figure 3. ACE inhibitors and ARBs have different sites of action within the RAS pathway. The solid arrows indicate activation, and the dashed arrows indicate inhibition. ACE = angiotensin-converting ...
Three large randomized trials tested a simple idea: if one blood-pressure drug that blocks the renin-angiotensin system protects diabetic kidneys, two such drugs should protect them better. Each trial ...
High blood pressure is one of the most common conditions affecting Americans. The CDC estimates that nearly half of adults in ...
Association of asynchronous, time-flexible digital multidisciplinary care with overall survival in advanced biliary tract cancer treated with immune checkpoint inhibitors. Envafolimab (KN035) plus ...
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)12 was a randomized controlled study of 45,000 persons with hypertension (BP >140/90) and one additional risk ...
Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results